Latest News2021-03-13T21:08:51+01:00
1407, 2021

New website CCE_DART

By |juli 14th, 2021|Categories: Cancer Core Europe|

New website CCE_DART The CCE_DART team launched the new web for the #H2020 Project. They are proud to be part of the Cancer Core Europe http://www.cce-dart.eu/

107, 2021

CCE_DART generated project quality guidelines

By |juli 1st, 2021|Categories: Cancer Core Europe|

CCE_DART generated project quality guidelines The CCE-DART quality guide lines define the general approach to quality assurance and the procedures to be followed for managing the production and review of the project outcomes, as well as for the development of the research activities. CCE_DART members should use this text as a reference document for quality management. It addresses the following sections: Project plan. Having a transparent [...]

107, 2021

CCE-DART Genral Assembly Update

By |juli 1st, 2021|Categories: Cancer Core Europe|

CCE-DART Genral Assembly Update Recently the CCE_DART General Assembly Update took place.  General Assembly Meetings (GAMs) will be held every year. Six months after the GAM a one-hour update will be organised to present the current status of the project to all participants. CCE_DART is a H2020 project that aims to incorporate newer, more effective methods to the design, conduct and analysis of clinical trials, with [...]

107, 2021

More experiences from the first TRYTRAC meeting

By |juli 1st, 2021|Categories: Cancer Core Europe|

More experiences from the first TRYTRAC meeting TRYTRAC offers the next generation research leaders a way to deepen their learning about each partner site and its state of the art research and technology. The aim is to build a strong future community network to seize opportunities of ideas from each partner, and together turn them into collaborative projects. The first digital workshop took place in  April: 6 sessions, [...]

107, 2021

CCE Lectures succesfull

By |juli 1st, 2021|Categories: Cancer Core Europe|

CCE Lectures succesfull Every month the Education and Training Taskforce organizes a CCE Lecture. And quite succesfull we can conclude. Although after a year of pandemic restrictions people migth be tired of Zoom-meetings, it is still an eays way of sharing the latest news and research information during lunch time. Without traveling. Laura Soucek, principal investigator mouse models of cancer therapies group at VHIO, Barcelona, focused [...]

107, 2021

New temporary members of the CCE Operational Board

By |juli 1st, 2021|Categories: Cancer Core Europe|

New temporary members of the CCE Operational Board Laura Pelz and Tanja Jutzi have been strengthening the CCE team for the NCT Heidelberg during the parental leave of Monika Huber and Petra Oberrauch. Katie Mills is managing the University of Cambridge contributions to CCE whilst Rebecca Bradley is on maternity leave.  Laura started on June 1st at the NCT Heidelberg and will take over for national cooperations. She also works in the [...]

107, 2021

New member of the Board of Directors

By |juli 1st, 2021|Categories: Cancer Core Europe|

New member of the Board of Directors Recently professor Richard Gilbertson joined the Board of Directors. Richard Gilbertson trained as a paediatric oncologist in the UK before moving in 2000 to St Jude Children’s Research Hospital, USA where he served as Scientific and Comprehensive Cancer Centre Director, Executive Vice President and Lillian R Cannon Endowed Chair.  In August 2015, he moved back home to England where he [...]

107, 2021

Registration Summer School 2021 open

By |juli 1st, 2021|Categories: Cancer Core Europe|

Registration Summer School 2021 open Registration is open for our Cancer Core Europe (CCE) Summer School in Translational Cancer Research, on the afternoons of October 13-14, 2021. Register early and benefit from an interactive format with limited available slots. This event will be offered free of charge. Find out about the program and register for this virtual event by October 8, 2021 https://summerschool.cancercoreeurope.eu/ This CCE educational event will [...]

2705, 2021

Ruud van der Noll leaves Cancer Core Europe

By |mei 27th, 2021|Categories: Cancer Core Europe|

Ruud van der Noll leaves Cancer Core Europe Ruud van der Noll has been involved in the network from the very beginning of Cancer Core Europe. First as coordinating officer, then as member of the operational board. A retrospective. How did you end up at Cancer Core Europe? “I first joined Cancer Core Europe through the involvement of my professor in the Clinical Trials task force. [...]

2705, 2021

Succesfull first digital TRYTRAC Program meeting

By |mei 27th, 2021|Categories: Cancer Core Europe|

Succesfull first digital TRYTRAC Program meeting TRYTRAC offers the next generation research leaders a way to deepen their learning about each partner site and its state of the art research and technology. The aim is to build a strong future community network to seize opportunities of ideas from each partner, and together turn them into collaborative projects. The first digital workshop took place on April 22 and 23. Six [...]

1803, 2021

Spearheading next generation clinical trials

By |maart 18th, 2021|Categories: Cancer Core Europe|

Cancer Core Europe’s design and development of data rich, dynamic studies in oncology Incorporating experts from the seven European comprehensive cancer centers belonging to the Cancer Core Europe (CCE) Consortium, along with an additional four non-CCE partners*, the EU-funded, multi-site project CCE Building Data Rich Clinical Trials (CCE-DART), has now launched. Coordinated by VHIO’s Elena Garralda, CCE-DART seeks to become a groundbreaking example in driving a novel generation [...]

1801, 2021

CCE’s own advanced training program TRYTRAC launched

By |januari 18th, 2021|Categories: Cancer Core Europe|

CCE’s own advanced training program TRYTRAC launched Education being the third pillar of CCE’s revised strategy, is a cornerstone to guarantee the sustainability of the consortium. The TRYTRAC program – “A European advanced TRaining program for Young cancer leaders in TRAnslational Cancer research” – was launched last November.The program aims to increase interactions between the clinical and translational researchers of the CCE member institutions. And it directs to promote [...]

1801, 2021

Valtteri Wirta is the new Genomics task force leader

By |januari 18th, 2021|Categories: Cancer Core Europe|

Valtteri Wirta is the new Genomics task force leader Since this month Valtteri Wirta is the new Genomics task force leader. He would like to take the opportunity to thank Lodewyk Wessels for coordinating in an excellent way the Genomics task force the last five years. And he introduces himself. “I have been a member and representative for KI in the Genomics task force since its launch five [...]

607, 2020

Seven European centres develop a web-based decision-making support tool for oncologist to improve treatment selection

By |juli 6th, 2020|Categories: Cancer Core Europe|

Seven European centres develop a web-based decision-making support tool for oncologist to improve treatment selection The increasing number and complexity of biomarkers that guide the selection of new therapies against cancer fragments knowledge on the biology of the disease and hinders the implementation of precision medicine. A new digital platform combines different cutting-edge bioinformatics methods with access to multiple databases to interpret the clinical relevance of the molecular [...]

1604, 2020

Adapted care for cancer patients due to COVID-19

By |april 16th, 2020|Categories: Cancer Core Europe|

Adapted care for cancer patients due to COVID-19 ABSTRACT Cancer Core Europe (CCE) have been forced by COVID-19 to adapt their approach to the treatment of patients with cancer. While still providing the same quality of care, of course. The specialist centres not only want to prevent the spread of the virus in general, but also to protect patients with cancer whose disease and treatment make them especially [...]

1303, 2019

Boosting the social impact of innovative cancer research – towards a mission-oriented approach to cancer

By |maart 13th, 2019|Categories: Cancer Core Europe|

Boosting the social impact of innovative cancer research – towards a mission-oriented approach to cancer The increasing cancer burden is one of the leading medical societal challenges today. The number of new cancer patients in Europe is expected to increase from 3.6 (2015) to 4.3 million over the next two decades; it has now reached 3.91 million. Moreover, the number of patients living with a cancer diagnosis is [...]

1203, 2019

Towards a mission‐oriented approach to cancer in Europe: an unmet need in cancer research policy

By |maart 12th, 2019|Categories: Cancer Core Europe|

Towards a mission‐oriented approach to cancer in Europe: an unmet need in cancer research policy ABSTRACT Today, cancer is a significant challenge for society, healthcare systems and the growing number of affected patients and their families. This article argues that new paradigms and conditions for responsible science and innovation policy across the European Union (EU) require (i) the collective action of Research & Development institutions, (ii) a system [...]

1203, 2019

New clinical trial designs in the era of precision medicine

By |maart 12th, 2019|Categories: Cancer Core Europe|

New clinical trial designs in the era of precision medicine ABSTRACT Cancer treatment has made significant strides towards the promise of personalized medicine. Recent scientific advances have shown that there are numerous genetic deregulations that are common in multiple cancer types, raising the possibility of developing drugs targeting those deregulations irrespective of the tumour type. Precision Cancer Medicine (PCM) was born out of accumulated evidence matching targeted agents [...]

1203, 2019

German Cancer Consortium (DKTK) – A national consortium for translational cancer research

By |maart 12th, 2019|Categories: Cancer Core Europe|

German Cancer Consortium (DKTK) – A national consortium for translational cancer research ABSTRACT The German Cancer Consortium (‘Deutsches Konsortium für Translationale Krebsforschung’, DKTK) is a long‐term cancer consortium, bringing together the German Cancer Research Center (DKFZ), Germany's largest life science research center, and the leading University Medical Center‐based Comprehensive Cancer Centers (CCCs) at seven sites across Germany. DKTK was founded in 2012 following international peer review and has [...]

702, 2019

Cancer Core Europe: A translational research infrastructure for a European mission on cancer

By |februari 7th, 2019|Categories: Cancer Core Europe|

Cancer Core Europe: A translational research infrastructure for a European mission on cancer ABSTRACT Cancer Core Europe is a European legal alliance consisting of seven leading cancer centres - most of them Comprehensive Cancer Centres (CCCs) - with a single portal system to engage in various research projects with partners. Cancer Core Europe was established to create a sustainable, high-level, shared research infrastructure platform hosting research collaborations and [...]

Ga naar de bovenkant